Clinical trialRSSYesterday
Final patient vist done in trial testing Celeste light therapy for Parkinson’s
A company called Photopharmics has finished testing a light therapy device called Celeste for Parkinson's disease. The last patient in the large study has completed all their visits. This is an important step toward potentially getting the device approved for patients to use.
WHY IT MATTERSCompletion of this pivotal trial means Celeste light therapy could move closer to FDA approval, potentially offering Parkinson's patients a new non-drug treatment option if results are positive.